Item 1.01. Entry into a Material Definitive Agreement.

On January 6, 2022, SLR Investment Corp. (the "Company") entered into a Fifth Supplement to Note Purchase Agreement, dated as of January 6, 2022 (the "Supplement"), to that certain Note Purchase Agreement dated as of November 8, 2016 (the "NPA"). Pursuant to the Supplement, on January 6, 2022, the Company issued to certain institutional investors, in a private placement, $135 million in aggregate principal amount of five-year, 3.33% unsecured notes due January 6, 2027 (the "Series 2016F Notes"), as an additional series of notes under the NPA. Except as set forth in the Supplement, the Series 2016F Notes have the same terms as the Series 2016A, Series 2016B, Series 2016C, Series 2016D and Series 2016E notes that were previously issued pursuant to the NPA, and the first supplement, second supplement, third supplement and fourth supplement thereto, respectively. Interest on the Series 2016F Notes will be payable semi-annually on January 6 and July 6 of each year, commencing July 6, 2022. The NPA also contains customary terms and conditions for unsecured notes issued in a private placement.

The description above is only a brief summary of the material provisions of the Supplement and is qualified in its entirety by reference to the Supplement, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth above under Item 1.01 is incorporated by reference herein.

Item 7.01. Regulation FD Disclosure.

On January 6, 2022 the Company issued a press release describing the issuance of the Series 2016F Notes, which is attached hereto as Exhibit 99.1 and incorporated by reference herein.

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.



(a) Not applicable.

(b) Not applicable.

(c) Not applicable.

(d) Exhibits.



      Exhibit No.                         Description

      10.1            Form of Fifth Supplement to Note Purchase Agreement

      99.1            Press release, dated January 12, 2022

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses